Health ❯ Pharmaceuticals ❯ Cancer Treatment

AI Applications

Recursion Pharmaceuticals

Recursion Soars on Heavy Volume as Investors Eye CEO’s AI Conference Appearance

Investors are positioning ahead of CEO Chris Gibson's Oct. 15 AI talk.